Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,137,822
-$659,367 QoQ
Shares Held
88,780
-10.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#926
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ancora Advisors LLC holds $96,816,715 across 11 Drug Manufacturers - General names. PFE ranks #6 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
229,968 | $58,404,972 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
121,465 | $15,345,887 | |
| 3 | AMGN |
Amgen Inc
|
34,637 | $12,542,749 | |
| 4 | LLY |
ELI LILLY & Co
|
3,182 | $3,816,586 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,902 | $2,685,906 | |
| 6 | PFE |
Pfizer Inc
This page
|
88,780 | $2,137,822 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
24,068 | $1,386,797 | |
| 8 | NVS |
Novartis AG
|
2,086 | $326,917 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,137,822 | 88,780 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,797,189 | 99,615 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,498,614 | 100,346 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,602,068 | 102,122 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,662,157 | 109,825 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,524,818 | 139,101 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $4,463,247 | 168,234 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,168,466 | 247,701 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,786,436 | 242,546 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $7,083,936 | 255,277 | Shares | Sole | 2024-05-16 | |
| 2023-12-31 | $7,154,890 | 248,520 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,984,464 | 180,418 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,866,348 | 187,196 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $7,533,229 | 184,638 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $9,333,263 | 182,148 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,235,190 | 165,338 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,518,668 | 162,477 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,160,286 | 176,942 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $10,872,817 | 184,129 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,952,549 | 184,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $7,076,681 | 180,712 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $6,476,474 | 178,760 | Shares | Sole | 2021-11-12 | |
| 2020-12-31 | $6,135,527 | 166,681 | Shares | Sole | 2021-11-12 | |
| 2020-09-30 | $5,248,938 | 143,023 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $4,224,352 | 129,185 | Shares | Sole | 2021-11-12 | |
| 2020-03-31 | $4,633,012 | 141,943 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||